Related by context. All words. (Click for frequent words.) 78 Vaxfectin TM formulated 73 Vaxfectin formulated 71 SynCon 70 TransVax tm 70 Vaxfectin ® 70 SynCon TM 69 PENNVAX ™ B 69 GVAX R 69 GVAX ® 69 ChronVac C 69 TransVax ™ 68 TransVax 68 SCIB1 68 TransVax TM 68 SynCon TM DNA 67 SynCon ™ DNA 67 MVA BN R 67 TBC M4 67 personalized dendritic 67 BiTE R 67 PENNVAX B 67 LEAPS TM 67 attach auristatin 67 CMV vaccine 67 Inovio SynCon ™ 66 SynCon ™ 66 Multimeric 66 Vaxfectin R adjuvant 66 virosome 66 Vaxfectin 66 GeoVax HIV AIDS 66 Inovio Pharmaceuticals 66 hemagglutination inhibition HAI 66 MVA BN ® 65 novel therapeutic antibodies 65 Immunotherapeutic 65 Generx ® 65 immuno therapeutic 65 NPC 1C 65 Vaccine Protects Against 65 human IgG1 monoclonal 65 Vaccine Adjuvant 65 synDNA TM 65 plasmid DNA pDNA 65 phosphatidylserine PS targeting 65 MCSP respectively 65 AdVac ® 65 Dendritic Cell 65 Adjuvanted 65 recombinant hepatitis B 64 Zalypsis 64 initiated Phase Ib 64 mda 7 64 PANVAC VF 64 TLR7 agonist 64 #T# tumor 64 dose intramuscular 64 Chimigen TM 64 Therapeutic Vaccine 64 agonistic human 64 ChronVac C R 64 Initiates Phase II 64 non nucleoside inhibitor 64 trivalent seasonal influenza 64 Phase 1a clinical 64 intranasal vaccines 64 Thiovir 64 ImmunoVEX 64 alferminogene tadenovec 64 Vitaxin 64 Intradermal 64 VRX# [001] 64 Vaxfectin adjuvant 64 CD# CEA 64 tadenovec Ad5FGF 4 64 Isolation Kit 64 Alfacell proprietary ribonuclease 64 GRNVAC1 63 investigational hepatitis B 63 OvaRex R 63 A/H#N# pandemic influenza 63 Valortim TM 63 DepoVax TM 63 potent suppressor 63 novel immunotherapeutic 63 Initiates Clinical 63 oncolytic virus therapies 63 NEUGENE R 63 H#N# VLP vaccine 63 trastuzumab DM1 T DM1 63 loaded dendritic cell 63 MVA nef 63 DermaVir 63 RNAi Therapeutic 63 Arcelis ™ 63 OncoVex 63 Presents Preclinical Data 63 Vaxfectin R 63 targeting CD# 63 recombinant influenza 63 DermaVir Patch 63 Virosome Biologicals 63 adecatumumab MT# 63 Preclinical Study 63 anti idiotype 63 specific CD8 + 63 anti CD3 monoclonal 63 multicenter Phase II 63 Vaxfectin TM 63 Reports Preclinical Data 63 Flavivirus 63 HCV polymerase 63 plasmid DNA encoding 63 SIX RO ROG 63 Nasdaq VICL 62 Begins Dosing 62 Pandemic Influenza Vaccine 62 Systemic Delivery 62 ZFP Therapeutics 62 Potelligent Technology 62 subunit vaccine 62 HuMax TAC 62 DPX Survivac 62 activated collagen gel 62 using Crucell PER.C6 62 T. parva 62 Plasmid DNA 62 kidney urologic 62 Inc. Nasdaq MAXY 62 modified vaccinia Ankara 62 selective orally bioavailable 62 PROSTVAC VF 62 HDL Selective Delipidation 62 vivo toxicology 62 MT#/MEDI-# 62 cellular immunotherapy 62 introduced NEUGENE 62 therapeutic monoclonal antibody 62 Phase Ib II 62 immunotherapeutic approaches 62 Novavax VLP vaccine 62 CA9 SCAN 62 Inovio DNA 62 orthopoxvirus 62 HuCAL antibodies 62 Inovio Biomedical Corp 62 novel immunotherapies 62 immunotherapeutic vaccine 62 anti botulism antibody 62 Neugene 62 Phase 2b Clinical Trial 62 pharmacogenomic translational research 62 OncoVEX 62 HEPLISAV ™ 62 CCR5 mAb 62 Achieves Primary Endpoint 62 UPLYSO 62 tramiprosate Alzhemed TM 62 hepatitis B measles mumps 62 Personalized Immunotherapy 62 Antibody Discovery 62 Rosetta Genomics Nasdaq ROSG 62 Varicella chicken pox 62 Pandemic Flu Vaccine 62 HIV coinfected 62 using Inovio MedPulser 62 plasmid DNA vaccine 62 Respiratory Virus 62 Rigel R# 62 LymphoStat B belimumab 62 RiVax 61 tests miRview TM 61 tkRNAi 61 cynomolgus macaques 61 Listeria vaccine 61 Tuberculosis Vaccine 61 Bayer HealthCare Onyx Pharmaceuticals 61 humanized monoclonal antibodies 61 adenovector 61 ChronVac C ® 61 immunotherapeutics 61 novel VDA molecule 61 Completes Patient Enrollment 61 LymphoStat B TM 61 lentiviral 61 staphylococcal vaccine 61 AFFITOME R 61 serogroup B 61 generation URAT1 inhibitor 61 inactivated influenza 61 Bordetella pertussis 61 trivalent influenza vaccine 61 Entry Inhibitor 61 Intercell Japanese Encephalitis 61 Antibody Drug Conjugate 61 Lpathomab 61 Nasdaq SGMO announced 61 Tarvacin TM 61 Inovio proprietary 61 Trastuzumab DM1 61 Selective Electrochemical Tumor Ablation 61 chimpanzee adenovirus 61 Phase lll 61 Omacetaxine 61 antibody reagents 61 Mycobacterial Cell Wall 61 anionic backbone 61 Immunomedics Announces 61 Imvamune R 61 Invasive pneumococcal disease 61 replicon 61 NS5b 61 MKC# MT 61 immatics 61 Kinase Inhibitor 61 MedPulser 61 Combination REOLYSIN R 61 XOMA 3AB 61 Inc. Nasdaq PPHM 61 RAV# 61 candidate Excellarate TM 61 Nasdaq IDRA today 61 BACcel ™ system 61 p# biomarker 61 non nucleoside HCV 61 cMET 61 RapidResponse TM DNA 61 Phase Ib IIa 61 SuperAntibody 61 Western Blotting 61 anti PlGF 61 ZFN modified 61 influenza VLP vaccine 61 Septin9 biomarker 61 Alferon N 61 Protein Expression 61 GV# [001] 61 purified inactivated vaccine 61 antisense inhibitors 61 cytotoxic T lymphocyte 61 poly ADP ribose polymerase 61 please visit www.advaxis.com 61 NEUGENE antisense 61 Prodarsan R 61 Oragene • 61 hyaluronidase enzyme 61 isoform selective 61 M2e 60 VLP influenza 60 TELINTRA R 60 ONCONASE R 60 MVA BN 60 PROSTVAC TM 60 ZFP Therapeutic 60 BACcelr8r TM 60 Initiate Clinical Trial 60 Universal Flu Vaccine 60 OTCBB PYTO 60 Tarvacin Anti Viral 60 rxRNA 60 Guanilib 60 TriGrid 60 OMP #M# 60 Sinovac vaccine 60 Viral Immunotherapy platform 60 humanised monoclonal antibody 60 simian foamy virus 60 Fibrin MB 60 Micromet BiTE 60 P#X# antagonist 60 recombinant subunit vaccine 60 Genocea Biosciences 60 BiTE ® 60 potent inducer 60 oral prodrug 60 A3 adenosine receptor 60 NEUGENE 60 huC# DM4 60 MVA MUC1 IL2 60 Transrenal DNA Tr 60 Nasdaq IDRA 60 Protexia R 60 Factor VIIa 60 Vical Incorporated Nasdaq VICL 60 apricitabine ATC 60 Juvaris BioTherapeutics 60 ImmunoCellular Therapeutics 60 hemagglutinin H 60 Phase 2a clinical trials 60 PCA3 gene 60 HGS ETR2 60 Glufosfamide 60 HCD# [002] 60 THR beta agonist 60 adenoviral vectors 60 oral picoplatin 60 DNA plasmids 60 product candidate Lpathomab 60 Epstein Barr Virus EBV 60 Hsp# Inhibitor 60 preclinical efficacy 60 recombinant soluble 60 Respiratory Syncytial Virus RSV 60 Vaxfectin TM adjuvant 60 BACcel 60 Septin 9 60 serologic 60 pDNA vaccine 60 stated Avtar Dhillon 60 Inovio Biomedical 60 IMA# 60 Adenoviral 60 Modified Vaccinia Ankara MVA 60 Elusys 60 Ad5FGF 4 60 DepoVax 60 GLP toxicology studies 60 selectively inhibit replication 60 MolecularBreeding TM 60 valent pneumococcal 60 humoral responses 60 StaphVAX R 60 Nasal Powder 60 Therapeutic Vaccines 60 Dynavax proprietary 60 Panzem R NCD 60 trivalent seasonal flu 60 platform HDL Mimetic 60 PDE# inhibitors 60 HTS assay 60 Phase III Pivotal 60 Hedgehog Pathway Inhibitor 60 nasal powder 60 Transfection 60 Initiate Phase 60 Crucell PER.C6 ® 60 5 HT2A serotonin 60 rPA anthrax vaccine 60 eTag assays 60 Chimigen 60 Aeolus Pharmaceuticals Announces 60 Tesmilifene 60 potently inhibit 60 VIRUSMAX TM 60 nucleotide analog 60 antibody MAb 60 Phase #b/#a clinical 60 envelope glycoprotein 60 DCVax R 60 demonstrated antitumor activity 60 BRIM2 60 tumor antigen 60 GTC NASDAQ GTCB 60 Phase 1b clinical trials 59 Immunotherapeutics 59 Spiegelmer ® 59 LAB CGRP 59 AAG geldanamycin analog 59 Georges Gemayel 59 Oncolytic 59 Archexin 59 orally administered inhibitor 59 Dendritic cell 59 NYSE Amex PBTH 59 Files Investigational 59 ZFP Therapeutic ® 59 MAGE A3 ASCI 59 TRACON Pharmaceuticals 59 ASX PGL 59 molecular diagnostic assay 59 DiLA2 59 NASDAQ HLCS 59 genomic biomarker 59 next generation URAT1 59 Hedgehog antagonist 59 volociximab 59 therapeutic monoclonal antibodies 59 JVRS 59 candidate REP# 59 ongoing Phase 1b 59 Monoclonal 59 rubella hepatitis 59 delipidation 59 MSCRAMM R 59 inactivated influenza virus 59 rhFVIIa 59 VeraTag 59 Dalradian Resources Inc. 59 EV# vaccine 59 Xcellerex FlexFactory 59 Rosetta Genomics microRNA 59 Vaccine Candidate 59 Files IND 59 HuCAL GOLD R 59 Phase IIb III 59 SNP Genotyping 59 RGDX 59 Altastaph 59 detection reagents 59 induces antibodies 59 Tesetaxel 59 PEG SN# 59 ENMD # 59 splice variants 59 KRAS mutant 59 Onconase 59 NS5A 59 transcriptome sequencing 59 Etubics 59 Posiphen TM 59 HCV Hepatitis C 59 DiLA2 Platform 59 compound AEZS 59 G#DT 59 anticancer therapeutics 59 XmAb 59 Aflunov 59 factor TNF receptor 59 VLP vaccine 59 torezolid 59 MALDI-TOF/TOF 59 Scancell 59 Nasdaq IVGN 59 Xcytrin R 59 investigational monoclonal antibody 59 taxane derivative 59 PhenoSense 59 varicella zoster virus VZV 59 Initiates Enrollment 59 Kahalalide F 59 AMEX RGN 59 Sphingomab TM 59 aurora kinase 59 Phase Ib study 59 Serological 59 Factor Receptor 59 Pharmacokinetics PK 59 recombinant adeno associated 59 preclinical pharmacology 59 SMaRT ™ 59 TLR9 agonist IMO 59 VIR# 59 IgM antibody 59 isotype 59 XL# anticancer compounds 59 novel peptides 59 Therapeutic Antibody 59 Inovio electroporation 59 Surfaxin LS 59 OpenArray ® 59 alkylated amino acid 59 humanized therapeutic 59 Kosan dependence 59 Presents Preclinical 59 DNA intercalator 59 recombinant polyclonal antibody 59 PSMA ADC 59 Janus kinase 59 NASDAQ CGEN announced 59 preclinical toxicology 59 preclinically 59 solithromycin 59 hepatoma 59 proprietary electroporation 59 LungAlert TM 59 accumulate preferentially 59 ultrasensitive detection 59 VeraCode 59 Oligonucleotide 59 lipid nanoparticle 59 SinuNase ™ 59 Polymerase Inhibitor 59 Staphylococcus aureus Polysaccharide Conjugate 59 Streptococcus agalactiae 59 GeoVax AIDS vaccine 59 Trofex 59 Allovectin 7 59 Merck Suspends Lobbying 59 Nanoemulsion 59 Nasdaq RDEA 59 MorphoSys proprietary 59 QuickVue R 59 Epitope 59 SparVax ™ 59 Illumina Solexa 59 ChimeriVax JE 59 includes TOLAMBA TM 59 transrenal DNA 59 virus HBV 59 experimentally validated 59 Morpholino 59 Solazed 59 platinum chemotherapeutic 59 deCODE AF TM 59 Valortim R 59 Streptococcus pneumonia 59 Corgentin 59 NanoStat 59 Confirmatory testing 59 mertansine 59 nonhuman primate model 59 Pruvel TM 59 FluChip 59 intranasal influenza 59 autologous cellular immunotherapy 59 Vaxart 59 Electroporation 59 Maxy G# 58 DOS# 58 Varicella zoster virus 58 refractory chronic lymphocytic 58 Epeius Biotechnologies Corporation 58 Situ Hybridization 58 AERAS-#/Crucell Ad# 58 Pathway Diagnostics 58 Patrice Milos 58 IIa clinical 58 3M Integrated Cycler 58 RainStorm 58 novel emulsion formulation 58 SmartChip TM Real 58 pharmacokinetic PK study 58 proprietary BiTE ® 58 PDGF B 58 monoclonal antibody mAb 58 SELDI TOF MS 58 fibrin derived 58 pneumonia tetanus 58 HuMax Inflam 58 CELVAPAN H#N# 58 Brussels THR 58 synDNA 58 DGAT1 inhibitors 58 Anticalin ® 58 t2cure GmbH 58 fidaxomicin Phase 58 Curaxin 58 Multiple Ascending Dose 58 developing TB4 58 IMC #B 58 nucleic acid assays 58 neuronal nicotinic receptor NNR 58 vitespen 58 Protease 58 PF # [002] 58 Topoisomerase II 58 Nasdaq PPHM 58 histone deacetylase HDAC 58 TCAD therapy 58 Preclinical Data 58 Aganocide 58 Activity Assay 58 Protexia ® 58 ALN TTR 58 Cancer Vaccines 58 Protein Interactions 58 APTIMA 58 tumorigenicity 58 GelVac TM 58 ospemifene 58 BioVant 58 including eniluracil ADH 58 Neogenix 58 personalized immunotherapy 58 virus AAV 58 CompoZr 58 targeted radiotherapeutic 58 Antitumor 58 fosbretabulin 58 Cytotoxic T 58 blood serum biomarkers 58 Phase Ib clinical 58 retaspimycin 58 Tem PCR 58 Monoclonal antibody 58 #T# L1 58 receptor inhibiting monoclonal 58 clears JonBenet Ramsey 58 Harry Palmin President 58 inhaled AAT 58 biologic therapeutics 58 NOD mouse 58 Antigen Specific 58 CYT# potent vascular disrupting 58 DEB# 58 protein tyrosine phosphatase 1B 58 VLP vaccine candidate 58 Japanese Encephalitis Vaccine 58 xTAG RVP 58 DCVax 58 Tß4 58 EndoBiologics 58 CEQ# 58 Fx #A 58 potently inhibited 58 AMD# [002] 58 IMVAMUNE TM 58 Demonstrates Significant 58 Aplidin 58 Respiratory Viral Panel 58 HBV HCV 58 cathepsin K inhibitor 58 Virological 58 protein biochip 58 Alferon LDO 58 PEGylated interferon 58 REGiMMUNE 58 Sphingomab 58 assay detects 58 SUCCEED trial 58 NASDAQ INFI 58 Dr. Ayalew Tefferi 58 NOD SCID mice 58 Gamma secretase 58 Nasdaq AVII 58 HPV cervical cancer 58 ATRA IV 58 Biologic License Application BLA 58 CYT# NicQb 58 NGNM 58 K RAS 58 Safinamide 58 HEPLISAV TM 58 Vaccine Shows Promise 58 CTAP# Capsules 58 Initiated Phase 58 pharmacodynamic markers 58 binding proteins ZFPs 58 methylation profiling 58 microdroplet based 58 pathophysiological effects 58 RNAi therapeutic targeting 58 ALK inhibitors 58 zinc finger nuclease 58 Vesivirus 58 Curaxin CBLC# 58 recombinant PSMA vaccine 58 ACE BioSciences 58 RiVax ™ 58 Sentrix 58 K ras mutations 58 www.nimblegen.com 58 BiTE antibodies targeting 58 MF# adjuvanted 58 selective kinase inhibitor 58 p# INK4a 58 Submits Response 58 NASDAQ AVII 58 virus HCV protease inhibitor 58 acid phosphatase PAP 58 vitro pharmacology 58 reverse vaccinology 58 evaluating satraplatin 58 epigenetic therapies 58 registrational trial 58 single molecule sequencing 58 PDE4 inhibitor 58 cytomegalovirus CMV 58 DNAwithPap Test 58 Novel Inhibitor 58 human immunodeficiency 58 HuMax EGFr 58 syngeneic 58 Source MDx 58 Inotek Pharmaceuticals Corporation 58 chickenpox varicella 58 peptide antigens 58 biostatistical analysis 58 brivanib 58 NIH NIAID 58 AMPK activators 58 LHRH receptor positive 58 promoter methylation 58 protein antigens 58 simplex virus 58 BioSante 2A/Furin technology 58 Recombinant Protein 58 technology Parthenogenesis 58 Deforolimus 58 euro adhoc Intercell AG 58 Bafetinib 58 non nucleoside 58 programs visit http:/www.bionovo.com 58 confirmatory clinical 58 xMAP technology 58 FluINsure 58 S OIV 58 molecular imaging radiopharmaceutical 58 penetrating peptides 58 PROVENGE ® 58 methylation markers 58 TLR9 agonist 58 peptide receptor 57 Monocytes 57 Vical researches 57 Vacc 4x 57 Panzem R 57 non porcine pancreatic 57 HuCAL PLATINUM 57 Viprovex TM 57 SinuNase TM 57 XYOTAX TM 57 FluCide 57 pharmacodynamic PD 57 chlamydia trachomatis 57 XmAb ® 57 SMT C# 57 Ostabolin C TM 57 ASONEP 57 Replikins 57 Phase III ADT 57 candidate deforolimus 57 Polysaccharide Diphtheria Toxoid Conjugate 57 generation antisense inhibitor 57 alvespimycin 57 Neuvenge 57 candidates Azedra TM 57 Amgen Neulasta R 57 Illumina GoldenGate 57 ddRNAi 57 MassARRAY platform 57 aT cell 57 Dr. Vitetta 57 NIAID Laboratory 57 Fc gamma receptors 57 bavituximab monotherapy trial 57 metabolite profiling 57 Sorrento Therapeutics 57 Modified Vaccinia Ankara 57 R roscovitine 57 dissolving microneedles 57 predictive toxicology 57 SAR# [004] 57 GeoVax vaccine 57 ELACYT 57 SNT-MC#/idebenone 57 PRESEPT 57 CELLECTRA R 57 GeoVax DNA 57 proprietary radiolabeled monoclonal 57 VRX# [002] 57 vivo validation 57 HuMax CD#b 57 Hepatitis C HCV 57 CRMD# 57 Virulizin ® 57 Sanofi Pasteur Fluzone 57 evaluating Prochymal 57 NASDAQ DVAX 57 GelVac ™ 57 NS4A 57 telomerase therapeutic 57 conserved antigens NP 57 transgenic rats 57 capsular polysaccharide 57 Amgen Neulasta ® 57 CCR9 57 NYSE Amex SVA 57 siRNA knockdown 57 PNT# 57 POTELLIGENT ® 57 COPEGUS therapy 57 JEV 57 drug conjugate 57 alemtuzumab MS 57 EGFr expressing metastatic colorectal 57 NASDAQ CXSP announced 57 investigational HCV polymerase 57 Genotyping Test 57 hc2 High Risk 57 ProNAi 57 Galenea 57 Epigenomics proprietary 57 Angiocept 57 Sangamo BioSciences 57 maturation inhibitor 57 HyperAcute 57 PNP inhibitor 57 innovative microdroplet based 57 RIGScan CR 57 Anti Tumor 57 #beta HSD 1 57 topoisomerase II inhibitor 57 TKM Ebola 57 live attenuated vaccines 57 DepoVax ™ 57 PREFLUCEL 57 viral tropism 57 TRX1 57 NuroPro R 57 GelVac TM powder 57 Phase IIb clinical trials 57 Anthrax Toxin 57 protein biochips 57 Pafuramidine 57 CRLX# 57 Medullary Thyroid Cancer 57 Sudhir Agrawal D.Phil 57 midstage clinical 57 AVXL 57 confirmatory pivotal 57 Quinvaxem TM 57 Anticalins R 57 Cloretazine ® 57 oral ghrelin agonist 57 Human Monoclonal Antibodies 57 Glybera R 57 Thorough cooking kills 57 lymphoid malignancies 57 Novel Vaccine 57 FOLOTYN ® 57 Nasdaq RGEN 57 tubulin inhibitor 57 lead Aganocide compound 57 murine monoclonal antibody 57 phase IIa 57 SEQureDx ™ 57 microRNA biomarkers 57 INCB# [001] 57 HuCNS SC ® 57 co stimulatory molecules 57 indolent follicular non 57 BHT DNA 57 potent cytotoxic 57 HQK 57 recurrent metastatic ovarian cancer 57 NS5B polymerase 57 SAR# [002] 57 IOMAI 57 Idera Pharmaceuticals 57 SPL# Gel vaginal microbicide 57 PRESEPT study 57 PRECISE trial 57 MKC# MKC# PP 57 WILEX AG 57 Pfenex Expression Technology 57 vivo preclinical 57 Exherin TM 57 Molecular Diagnostic 57 Prima BioMed 57 Affymetrix GeneChip ® 57 JOULFERON 57 MAGE A3 57 polyclonal 57 essential thrombocythemia ET 57 OvaRex MAb 57 meningococcal serogroup B 57 HemoGenix 57 recombinant antibodies 57 Awarded Qualifying Therapeutic 57 Allovectin 7 R 57 optimal dosing regimens 57 Oncotype DX colon cancer 57 VIRxSYS 57 Hepatocytes 57 MassARRAY R 57 CINtec R 57 Submits Biologics License Application 57 ASONEP ™ 57 thymidine kinase 57 rhLF 57 optical biosensors 57 glycan microarray 57 alpha#beta# integrin 57 lymphoid tumors 57 MChip 57 oligonucleotide ligation 57 Inc. Nasdaq VRUS 57 Immunogenicity 57 HLA DQ2 57 Xelox 57 Serologic 57 Antitumor Activity 57 OTCBB PWRM.OB 57 Nonclinical 57 proprietary PEGylation 57 Present Preclinical Data 57 BRAF mutant 57 Licenses Novel 57 ALN PCS 57 vapreotide acetate 57 selectively inhibited 57 EXACT Sciences stool 57 mediated inhibition 57 Vaccine Adjuvants 57 VivaGel ™ 57 TACI Ig 57 metabolite identification 57 trial evaluating PRX# 57 biased ligand 57 Solorel TM 57 Pichia pastoris 57 FLUPAN 57 Influenza Virus 57 GelVac 57 XL# inhibits 57 CHEMSAS R 57 evaluating tivozanib 57 Lovaxin C 57 HCV replicon 57 OTCBB UGNE http:/www.unigene.com 57 RhuDex R 57 immunotherapeutic agent 57 ANTISENILIN R 57 Phase #b/#a 57 Nobilon 57 recurrent metastatic 57 ZFN 57 Shigamabs ® 57 AQUA ® 57 RNA interference RNAi therapeutics 57 VaxInnate 57 treatment naive genotype 57 AFREZZA TM 57 INTERCEPT red 57 Cites Positive 57 Janus Kinase 57 nasopharyngeal swabs 57 generation purine nucleoside 57 acyclovir Lauriad R 57 Affilin ® 57 metabolomics driven 57 anaplastic lymphoma kinase ALK 57 KRYSTEXXA TM pegloticase 57 ACTCellerate 57 annexin 57 enteroviral 57 receptor tyrosine kinase inhibitor 57 Aurora Kinase 57 CCR5 receptor antagonist 57 evaluating satraplatin plus 57 chromatin immunoprecipitation ChIP 57 antibody MT# 57 trodusquemine 57 delivery polymer matrix 57 Polymorphisms 57 Silodosin 57 BrainGate TM 57 Initiates Clinical Trials 57 AERAS 57 Immunostimulatory 57 Salix Pharmaceuticals Announces 57 successfully commercialize Iluvien 57 GlaxoSmithKline Biologicals GSK 57 PhG alpha 1 57 include ColorectAlert TM 57 interferon lambda 57 constitutively expressed 57 Announces Poster Presentations 57 metabolomic profiling 57 Locked Nucleic Acid LNA 57 adenoviral 57 tolevamer 57 ToGA 57 Empatic ™ 57 Hybridon 57 molecular biology genomics proteomics 57 Oral Calcitonin 57 inactivated poliovirus 57 Trofex TM 57 MenACWY 57 Epiphany Biosciences 57 Civacir 57 Inc. AMEX YMI 57 Gets FDA Clearance 57 NADiA R 57 CoVal TM fusion 57 HGS ETR1 57 Kinoid 57 pediatric acute lymphoblastic 57 Human papillomavirus 57 Dr. Pasinetti 57 Pandemic Influenza Vaccines 57 SoftScan ® 57 Randomized Phase 56 Diagnostic Tests 56 Panzem 56 multiplex assays 56 ASCO GU 56 samalizumab 56 treatment naïve genotype 56 NV1FGF 56 Breast Cancer Assay 56 ganetespib 56 Shows Promising 56 EDEMA3 56 Shows Promise Against 56 chimeric monoclonal antibody 56 Profectus BioSciences 56 TRAIL receptor 56 Urocidin 56 vivo efficacy 56 oncolytic 56 Apoptone 56 viral antigen 56 Azedra ™ 56 idiotype vaccines 56 Co Receptor Tropism 56 Liposomal